| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $17,011,594 ) (Continued on the next page) |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS127292 | Molecular mechanisms for sorting lysosomal proteins | 000 | 5 | NIH | 6/3/2026 | $475,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS142598 | Mechanisms of gain-of-repeat-toxicity and loss-of-C9ORF72-function in FTD and ALS | 000 | 1 | NIH | 2/27/2026 | $555,128 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R00CA286742 | The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer | 000 | 4 | NIH | 6/26/2026 | $183,769 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS146544 | Neurodegenerative Mechanisms of ATP13A2-linked Parkinson's Disease and Related Disorders | 000 | 1 | NIH | 3/10/2026 | $582,465 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM165630 | Regulation of Endoplasmic Reticulum (ER) Quality Control Across Cell types with Unique ER morphologies. | 000 | 1 | NIH | 7/1/2026 | $528,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30NS149794 | Dissecting neuronal molecular trajectories and glial responses to α-synuclein aggregates in Lewy body diseases | 000 | 1 | NIH | 7/6/2026 | $52,114 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA305570 | Targeting mechanisms of chromatin plasticity to improve the efficacy of epigenetic solid tumor therapy | 001 | 1 | NIH | 5/19/2026 | $3,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA269394 | Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death | 000 | 5 | NIH | 5/14/2026 | $496,922 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM160317 | Revealing the Molecular Basis of Microtubule-Intermediate Filament Interactions. | 000 | 2 | NIH | 6/3/2026 | $528,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U01CA297713 | Dietary regulation of anti-tumor immunity through caloric restriction | 000 | 2 | NIH | 4/9/2026 | $767,324 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES034253 | Molecular mechanisms of iAs-mediated carcinogenesis through the lens of histone H2B variants | 000 | 5 | NIH | 2/11/2026 | $666,885 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 000 | 3 | NIH | 4/28/2026 | $49,114 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U01CA286580 | Diet-mediated regulation of fatty acid saturation impacts cancer progression and therapy responses. | 000 | 3 | NIH | 5/1/2026 | $796,798 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152184 | Molecular mechanisms of chromatin signaling and epigenetic regulation | 000 | 3 | NIH | 5/22/2026 | $518,400 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI165580 | Elucidating the Structural Mechanisms of NAIP Receptors in Bacterial Detection and Inflammasome Activation | 000 | 5 | NIH | 12/29/2025 | $480,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES036051 | circSATB2, a novel regulator of arsenic-induced carcinogenesis | 000 | 3 | NIH | 12/16/2025 | $632,177 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R25HG011020 | Epigenomics Workshop for Graduate Students | 000 | 5 | NIH | 12/15/2025 | $51,777 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG084743 | Accelerated DNA Methylation Alterations in Hutchinson-Gilford Progeria Syndrome | 000 | 4 | NIH | 6/11/2026 | $783,592 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152081 | Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity | 001 | 4 | NIH | 3/10/2026 | $62,573 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152081 | Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity | 000 | 4 | NIH | 1/30/2026 | $563,163 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R13HD122433 | Midwest Zebrafish Meeting 2026 | 000 | 1 | NIH | 6/9/2026 | $20,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG083568 | Endogenous retrovirus in joint aging and osteoarthritis development | 000 | 4 | NIH | 4/9/2026 | $585,279 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG077573 | Network and cellular vulnerability to pathological protein progression | 000 | 5 | NIH | 5/7/2026 | $440,318 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM151245 | Regulation of mitochondrial fatty acid synthesis in the control of mitochondrial metabolism. | 000 | 4 | NIH | 5/14/2026 | $475,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM131754 | Structural mechanism of DNA replication | 000 | 8 | NIH | 5/5/2026 | $720,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K22CA272912 | Oncoprotein-regulated lineage plasticity in acute leukemia | 000 | 3 | NIH | 5/5/2026 | $192,240 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01MH139201 | The immunobiological mechanisms of depression in perimenopause | 000 | 2 | NIH | 1/16/2026 | $765,613 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AR084693 | Sexually dimorphic regulation of bone mass by the X-linked histone modifier KDM5C | 000 | 3 | NIH | 6/19/2026 | $620,093 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM145378 | Mechanisms of mutant mitochondrial genome modulation | 004 | 6 | NIH | 3/10/2026 | $48,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM145378 | Mechanisms of mutant mitochondrial genome modulation | 002 | 6 | NIH | 1/21/2026 | $432,000 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA276031 | Mechanisms of cancer mutations | 001 | 4 | NIH | 4/16/2026 | $48,255 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA276031 | Mechanisms of cancer mutations | 000 | 4 | NIH | 12/10/2025 | $434,294 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA283463 | Mechanisms of DNA methylation signaling and dysregulation in colon cancer | 001 | 3 | NIH | 7/7/2026 | $1,896,957 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI194519 | Investigating KDM5C as a regulatory switch between anabolic and catabolic metabolism | 000 | 1 | NIH | 4/24/2026 | $886,437 |
| | 2026 | 2026 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA231466 | Molecular mechanisms of protein glycosylation and trafficking | 000 | 9 | NIH | 6/11/2026 | $475,000 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA305570 | Targeting mechanisms of chromatin plasticity to improve the efficacy of epigenetic solid tumor therapy | 000 | 1 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA294248 | Determinants of susceptibility to pediatric acute myeloid leukemia | 000 | 2 | NIH | 11/26/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F31AG084199 | Identifying Determinants of Tau Pathology Seeding | 000 | 2 | NIH | 1/16/2026 | -$27,061 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA268440 | High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader | 000 | 4 | NIH | 12/4/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA284282 | Impact of neurofibromin on ER-alpha and nuclear speck post-transcriptional gene regulation | 000 | 2 | NIH | 4/22/2026 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F31NS139616 | Cortical Neuronal Vulnerability in Parkinson's Disease | 000 | 1 | NIH | 11/17/2025 | -$21,887 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30CA268840 | A Molecular Case Series: Deep Cellular and Spatial Epigenetic Characterization of Human Colorectal Cancer | 000 | 3 | NIH | 1/7/2026 | -$54,537 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | T32CA251066 | Cancer Epigenetics Training (CET) Program | 000 | 5 | NIH | 5/28/2026 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01HG012444 | Master regulators of unexplained variation in disease risk | 000 | 5 | NIH | 6/9/2026 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01GM143308 | A NOVEL PROCESS SAFEGUARDS GENOME INTEGRITY IN THE MAMMALIAN GERM LINE | 000 | 4 | NIH | 3/25/2026 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AR079174 | 5-methylcytosine oxidation in development and disease | 000 | 5 | NIH | 1/9/2026 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS120489 | LRRK2 Enzymatic Mechanisms of Neurodegeneration in Parkinson's Disease | 000 | 5 | NIH | 5/19/2026 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K99CA286742 | The role of AHR in modulatingimmunotherapy response and adverse events in bladder cancer | 000 | 2 | NIH | 11/24/2025 | $0 |
| | 2026 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM145378 | Mechanisms of mutant mitochondrial genome modulation | 001 | 5 | NIH | 12/18/2025 | $315,817 |
|
